ESRRA and breast carcinoma: However, the XCT790-induced protein reduction of ERRα in VCaP cells could be prevented by a proteasome inhibitor MG132 (Supplementary Fig. S2c), suggesting that such ERRα reduction was mediated by an enhanced proteasomal degradation mechanism as similarly reported in MCF7 breast cancer cells [30].